source
- BioNTech appoints Sobi head Guido Oelkers as new CEO to steer oncology shiftBioNTech announced that Guido Oelkers, who has led the rare‑disease focused Swedish company Sobi since 2017, will become its next chief executive officer. Oelkers is slated to take over the role b…
- BioNTech appoints Guido Oelkers as new CEO, succeeding cofounder Ugur SahinBioNTech announced that Guido Oelkers will become its chief executive officer, taking over from cofounder Ugur Sahin. Oelkers comes from Swedish biopharma Sobi, where he led the company, and bring…